antiarrhythmic therapy

antiarrhythmic therapy

Cardiology The use of therapeutic agents to counteract potentially life-threatening and refractory ventricular arrhythmias, and ↓ mortality; the Vaughn Williams/Harrison classification divides antiarrhythmic agents into 5 groups. Cf Proarrhythmic effect.
References in periodicals archive ?
Indeed, the future of antiarrhythmic therapy lies in neuromodulation of the autonomic nervous system, and it's a lot closer than most cardiologists realize, according to the electrophysiologist.
Lignocaine should not be used as antiarrhythmic therapy.
Thus, it will definitely expand our understanding of antiarrhythmic therapy from the pharmacological stand point of view.
Chronic antiarrhythmic therapy is not necessary, however; atrial flutter associated with postoperative procedure may be resistance to electrical cardioversion or persistent, requiring the use of antiarrhythmic medications (1, 5).
Upon discharge, antiarrhythmic therapy with low-dose amiodarone at 200 mg daily was continued based on the judgment of the investigators and consultant cardiologists.
Prolongation of the QT interval can be associated with life-threatening drug-induced side effects such as Torsades de Pointes, and has traditionally presented a significant challenge for antiarrhythmic therapy.
Implantable cardioverter defibrillator (ICD) has been shown to decrease the incidence of SCD in primary prevention in patients with LV systolic dysfunction, as well as in secondary prevention when compared to antiarrhythmic therapy.
Ventricular arrhythmias requiring increased antiarrhythmic therapy were common in both groups.
Updated American College of Cardiology (ACC) American Heart Association (AHA) and European Society of Cardiology (ESC) atrial fibrillation (AF) guidelines support the use of propafenone as a first-line antiarrhythmic therapy option for managing patients with AF who require antiarrhythmic therapy and have no underlying heart disease or are without substantial left ventricular hypertrophy.
6% of RealiseAF patients on amiodarone as first-line antiarrhythmic therapy, one-half did not qualify according to the 2006 joint American College of Cardiology/American Heart Association/European Society of Cardiology AF guidelines.
Response to long-term antiarrhythmic therapy for the prevention of further episodes of tachycardia in patients with WPW syndrome remains quite variable and unpredictable.